Market Cap 707.9M

Saniona is a drug research and development company based in Copenhagen. The company target diseases in the area of Central Nervous System (CNS), metabolic diseases, autoimmune diseases, and treatment of pain. The research platform is focused on ion channels which controls the passage of charged ions across cell membranes. The company was founded in 2011 and has some 24 employees. Saniona has been listed since 2014, and is since 2017 listed on the main market of OMX Nasdaq Stockholm (List: Small Cap).

+ more

Redeye Research